LIVN

LivaNova PLC NASDAQ

Healthcare ·Medical - Devices ·GB · livanova.com

$59.07

Mkt Cap $3.2B

52w Low $35.00 65.2% of range 52w High $71.92

50d MA $64.17 200d MA $58.58

P/E (TTM) -13.7x

EV/EBITDA -24.6x

P/B 2.8x

Debt/Equity 0.4x

ROE -20.2%

P/FCF 19.4x

RSI (14) —

ATR (14) —

Beta 0.97

50d MA $64.17

200d MA $58.58

Avg Volume 831.3K

About

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, c…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 25, 2026	AMC	0.80	0.86	+7.5%	70.29	+0.3%	+1.0%	+0.4%	-0.0%	-2.6%	-7.2%	—
Nov 5, 2025	AMC	0.92	1.11	+20.8%	50.81	+0.7%	-2.4%	-0.7%	+0.1%	+3.7%	+11.4%	—
Aug 6, 2025	AMC	0.84	1.05	+25.0%	47.36	+1.0%	+2.4%	+3.1%	+4.6%	+6.9%	+12.0%	—
May 7, 2025	AMC	0.75	0.88	+17.3%	43.50	+1.7%	+1.3%	+1.3%	+4.0%	+1.3%	+0.1%	—
Feb 25, 2025	AMC	0.80	0.81	+1.2%	41.70	-1.7%	-0.6%	-1.8%	-0.2%	+0.0%	-0.3%	—
Oct 30, 2024	AMC	0.71	0.90	+26.8%	51.34	-0.5%	+0.5%	-0.4%	-4.5%	-3.2%	+1.5%	—
Jul 31, 2024	AMC	0.79	0.93	+17.7%	49.40	+0.9%	-2.2%	-4.9%	-8.4%	-7.2%	-9.5%	—
May 1, 2024	AMC	0.45	0.73	+62.2%	62.62	+0.0%	+0.5%	+2.4%	-0.0%	+0.8%	-0.3%	—
Feb 21, 2024	AMC	0.79	0.87	+10.1%	56.82	-0.1%	-1.0%	+0.5%	-1.5%	-1.6%	-3.0%	—
Nov 1, 2023	AMC	0.62	0.73	+17.7%	50.04	+1.9%	-2.7%	-0.2%	-2.9%	-5.1%	-5.7%	—
Jul 26, 2023	AMC	0.58	0.78	+34.5%	58.87	+0.9%	-2.6%	-1.8%	-0.7%	-0.5%	-2.4%	—
May 3, 2023	AMC	0.41	0.43	+4.9%	47.50	-0.5%	-0.2%	-0.0%	-0.8%	-1.6%	-1.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 27	Barclays	Maintains	Equal Weight → Equal Weight	—	$71.00	$70.52	-0.7%	-0.6%	-1.0%	-3.6%	-8.1%	-8.9%
Feb 25	Needham	Maintains	Buy → Buy	—	$69.05	$64.16	-7.1%	+1.8%	+2.8%	+2.2%	+1.8%	-0.9%
Jan 9	Barclays	Maintains	Equal Weight → Equal Weight	—	$64.95	$64.66	-0.4%	-0.8%	-4.0%	-5.6%	-6.3%	-2.7%
Jan 7	Stifel	Maintains	Buy → Buy	—	$64.12	$64.32	+0.3%	+0.8%	+1.3%	+0.5%	-2.7%	-4.4%
Dec 17	Mizuho	Maintains	Outperform → Outperform	—	$63.08	$62.74	-0.5%	+0.0%	-1.6%	-0.4%	-0.0%	+0.3%
Nov 13	Baird	Maintains	Outperform → Outperform	—	$56.62	$56.62	+0.0%	-2.5%	-2.2%	-5.3%	-4.8%	-4.8%
Nov 13	Mizuho	Maintains	Outperform → Outperform	—	$56.62	$56.62	+0.0%	-2.5%	-2.2%	-5.3%	-4.8%	-4.8%
Nov 6	Baird	Maintains	Outperform → Outperform	—	$50.81	$51.17	+0.7%	-2.4%	-0.7%	+0.1%	+3.7%	+11.4%
Sep 3	Needham	Maintains	Buy → Buy	—	$56.92	$56.81	-0.2%	-0.6%	+2.2%	+1.8%	+2.5%	+3.2%
Aug 21	Barclays	Maintains	Equal Weight → Equal Weight	—	$53.39	$53.37	-0.0%	-1.0%	+4.7%	+5.5%	+6.0%	+5.8%
May 20	Wolfe Research	Upgrade	Peer Perform → Outperform	—	$43.97	$44.87	+2.0%	+2.1%	-0.7%	-1.8%	-4.8%	+0.1%
May 13	Needham	Maintains	Buy → Buy	—	$45.23	$45.04	-0.4%	-2.6%	-3.7%	-3.1%	-1.8%	-2.8%
May 8	Baird	Maintains	Outperform → Outperform	—	$43.50	$44.23	+1.7%	+1.3%	+1.3%	+4.0%	+1.3%	+0.1%
May 8	Barclays	Maintains	Equal Weight → Equal Weight	—	$43.50	$44.23	+1.7%	+1.3%	+1.3%	+4.0%	+1.3%	+0.1%
Mar 17	Needham	Maintains	Buy → Buy	—	$39.24	$39.50	+0.7%	+5.5%	+3.0%	+4.1%	+3.0%	+0.6%
Mar 7	Barclays	Maintains	Equal Weight → Equal Weight	—	$39.99	$39.85	-0.4%	-2.1%	-7.4%	-2.3%	-2.3%	-3.6%
Mar 3	Goldman Sachs	Maintains	Buy → Buy	—	$41.63	$42.23	+1.4%	+0.2%	-0.2%	-1.8%	-3.9%	-5.9%
Feb 26	Mizuho	Maintains	Outperform → Outperform	—	$41.70	$41.01	-1.7%	-0.6%	-1.8%	-0.2%	+0.0%	-0.3%
Feb 26	Needham	Maintains	Buy → Buy	—	$41.70	$41.01	-1.7%	-0.6%	-1.8%	-0.2%	+0.0%	-0.3%
Feb 26	Stifel	Maintains	Buy → Buy	—	$41.70	$41.01	-1.7%	-0.6%	-1.8%	-0.2%	+0.0%	-0.3%
Jan 28	Needham	Maintains	Buy → Buy	—	$49.53	$49.75	+0.4%	+2.0%	+2.4%	+2.2%	+0.8%	-3.0%
Nov 25	Needham	Maintains	Buy → Buy	—	$51.32	$51.49	+0.3%	+0.8%	-1.2%	+2.3%	+2.3%	+1.9%
Nov 12	Needham	Maintains	Buy → Buy	—	$51.81	$52.00	+0.4%	+2.3%	+3.4%	+1.0%	+0.6%	+1.4%
Oct 31	Needham	Maintains	Buy → Buy	—	$51.34	$51.08	-0.5%	+0.5%	-0.4%	-4.5%	-3.2%	+1.5%
Oct 31	Baird	Maintains	Outperform → Outperform	—	$51.34	$51.08	-0.5%	+0.5%	-0.4%	-4.5%	-3.2%	+1.5%
Oct 31	Mizuho	Maintains	Outperform → Outperform	—	$51.34	$51.08	-0.5%	+0.5%	-0.4%	-4.5%	-3.2%	+1.5%
Sep 17	Baird	Upgrade	Neutral → Outperform	—	$48.79	$50.37	+3.2%	+4.5%	+4.7%	+5.0%	+4.0%	+5.2%
Aug 28	Baird	Maintains	Neutral → Neutral	—	$46.60	$46.50	-0.2%	+3.7%	+7.8%	+8.1%	+6.4%	+5.3%
Aug 1	Baird	Maintains	Neutral → Neutral	—	$49.40	$49.86	+0.9%	-2.2%	-4.9%	-8.4%	-7.2%	-9.5%
Jul 31	Needham	Maintains	Buy → Buy	—	$51.30	$53.27	+3.8%	-3.7%	-5.8%	-8.4%	-11.8%	-10.7%
Jul 25	Stifel	Maintains	Buy → Buy	—	$53.77	$54.19	+0.8%	-0.6%	-0.3%	-2.8%	-4.6%	-8.1%
Jun 6	Needham	Maintains	Buy → Buy	—	$60.03	$52.63	-12.3%	-12.0%	-11.1%	-12.0%	-13.8%	-12.0%
May 2	Baird	Maintains	Neutral → Neutral	—	$62.62	$62.63	+0.0%	+0.5%	+2.4%	-0.0%	+0.8%	-0.3%
May 2	Mizuho	Maintains	Buy → Buy	—	$62.62	$62.63	+0.0%	+0.5%	+2.4%	-0.0%	+0.8%	-0.3%
May 1	Needham	Maintains	Buy → Buy	—	$55.75	$59.90	+7.4%	+12.3%	+12.9%	+15.1%	+12.3%	+13.2%
Mar 27	Mizuho	Maintains	Buy → Buy	—	$54.39	$54.69	+0.6%	+2.7%	+2.8%	+1.4%	-0.1%	-0.8%
Mar 20	Needham	Maintains	Buy → Buy	—	$50.34	$51.25	+1.8%	+12.5%	+11.8%	+11.2%	+8.1%	+8.0%
Feb 27	Barclays	Maintains	Equal Weight → Equal Weight	—	$55.97	$56.31	+0.6%	-0.1%	-1.6%	-2.1%	-1.3%	-0.2%
Feb 26	Barclays	Maintains	Equal Weight → Equal Weight	—	$57.12	$56.86	-0.5%	-2.0%	-2.1%	-3.6%	-4.0%	-3.3%
Feb 22	Baird	Maintains	Neutral → Neutral	—	$56.82	$56.78	-0.1%	-1.0%	+0.5%	-1.5%	-1.6%	-3.0%
Feb 22	Mizuho	Maintains	Buy → Buy	—	$56.82	$56.78	-0.1%	-1.0%	+0.5%	-1.5%	-1.6%	-3.0%
Feb 21	Needham	Maintains	Buy → Buy	—	$52.60	$55.50	+5.5%	+8.0%	+6.9%	+8.6%	+6.4%	+6.3%
Feb 20	Mizuho	Upgrade	Neutral → Buy	—	$49.88	$50.92	+2.1%	+5.5%	+13.9%	+12.8%	+14.5%	+12.2%
Nov 17	Needham	Maintains	Buy → Buy	—	$47.24	$47.64	+0.8%	-1.0%	-0.8%	-8.0%	-6.8%	-6.6%
Oct 23	Needham	Maintains	Buy → Buy	—	$49.41	$49.18	-0.5%	-2.5%	-2.0%	-3.6%	-4.6%	-4.5%
Jul 27	Barclays	Maintains	Equal Weight → Equal Weight	—	$58.87	$59.41	+0.9%	-2.6%	-1.8%	-0.7%	-0.5%	-2.4%
Jul 27	Baird	Maintains	Outperform → Outperform	—	$58.87	$59.41	+0.9%	-2.6%	-1.8%	-0.7%	-0.5%	-2.4%
Jul 26	Needham	Maintains	Buy → Buy	—	$53.58	$58.05	+8.4%	+9.9%	+7.0%	+7.9%	+9.1%	+9.3%
May 8	Barclays	Maintains	Equal Weight → Equal Weight	—	$47.48	$47.58	+0.2%	-0.8%	-1.6%	-1.1%	-1.0%	-0.9%
May 3	Needham	Maintains	Buy → Buy	—	$47.13	$45.24	-4.0%	+0.8%	+0.6%	+0.7%	-0.0%	-0.8%

Recent Filings

8-K

LivaNova PLC -- 8-K Filing

LivaNova's VNS Therapy gained CMS reimbursement coverage for drug-resistant epilepsy while its cloud-based digital platform received FDA approval, potentially expanding market access and revenue streams.

Feb 25

Data updated apr 25, 2026 7:19pm · Source: massive.com